A suspicion of chikungunya leading to a diagnosis of angioimmunoblastic T-cell lymphoma

References

• Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007; 7: 319–27
   PubMed Web of Science ®Google Scholar
• The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 2000;50:696–702.
   PubMed Web of Science ®Google Scholar
• Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, et al. Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 2007; 48(4)716–22
   PubMed Web of Science ®Google Scholar
• Lennert K, Feller A. Histopathology of non-Hodgkin's lymphomas. Springer-Verlag, New York 1992
   Google Scholar
• Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma: Pathobiological insights and clinical implications. Curr Opin Hematol 2007; 14: 348–53
   PubMed Web of Science ®Google Scholar
• Attygalle AD, Chuang SS, Diss TC, Du MQ, Isaacson PG, Dogan A. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007; 50: 498–508
   PubMed Web of Science ®Google Scholar
• Dupuis, J, Boye, K, Martin, N, Copie-Bergman, C, Plonquet, A, Fabiani, B, , et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): A new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006;30:490–4.
   PubMed Web of Science ®Google Scholar
• Luppi M, Barozzi P, Maiorana A, Artusi T, Trovato R, Marasca R, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996; 87(9)3903–9
   PubMed Web of Science ®Google Scholar
• Kang HY, Hwang JH, Park YS, Bang SM, Lee JS, Chung JH, et al. Angioimmunoblastic T-cell lymphoma mimicking Crohn's disease. Dig Dis Sci 2007; 52(10)2743–7
   PubMed Web of Science ®Google Scholar
• Saito M, Fukuda T, Shiohara T, Homori M. Angioimmunoblastic T-cell lymphoma: A relatively common type of T-cell lymphoma in Sjogren's syndrome. Clin Exp Rheumatol 2005; 23: 888–90
   PubMed Web of Science ®Google Scholar
• Tsochatzis E, Vassilopoulos D, Deutsch M, Filiotou A, Tasidou A, Archimandritis AJ. Angioimmunoblastic T-cell lymphoma-associated arthritis: Case report and literature review. J Clin Rheumatol 2005; 11: 326–8
   PubMed Web of Science ®Google Scholar
• Batinac T, Zamolo G, Jonjic N, Gruber F, Nacinovic A, Seili-Bekafigo I, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration. Tumori 2003; 89(1)91–5
   PubMed Web of Science ®Google Scholar
• Pay S, Dinc A, Simsek I, Can C, Erdem H. Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. Rheumatol Int 2000; 20: 25–7
   PubMed Web of Science ®Google Scholar
• Ozyilkan O, Ozyilkan E, Karagoz F, Ozdamar S, Kandemir B. Hepatitis C virus infection and angioimmunoblastic lymphadenopathy. Am J Gastroenterol 1995; 90: 1029–30
   PubMed Web of Science ®Google Scholar
• Rho R, Laddis T, McQuain C, Selves J, Woda B, Knecht H. Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy. Ann Hematol 1996; 72: 333–5
   PubMed Web of Science ®Google Scholar
• van den BC, Lloyd G. Chikungunya fever as a risk factor for endemic Burkitt's lymphoma in Malawi. Trans R Soc Trop Med Hyg 2000; 94: 704–5
   PubMed Web of Science ®Google Scholar
• Advani R, Horwitz S, Zelenetz A, Horning SJ. Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine. Leuk Lymphoma 2007; 48: 521–5
   PubMed Web of Science ®Google Scholar
• Tsatalas C, Margaritis D, Pantelidou D, Spanudakis E, Kaloutsi V, Bourikas G. Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. Acta Haematol 2003; 109: 110
   PubMed Web of Science ®Google Scholar
• Sallah S, Wehbie R, Lepera P, Sallah W, Bobzien W. The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia. Br J Haematol 1999; 104: 163–5
   PubMed Web of Science ®Google Scholar
• Halene S, Zieske A, Berliner N. Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab. Nat Clin Pract Oncol 2006; 3: 165–8
   PubMedGoogle Scholar
• Quintini G, Iannitto E, Barbera V, Turri D, Franco V, Florena AM, et al. Response to low-dose oral methotrexate and prednisone in two patients with angio-immunoblastic lymphadenopathy-type T-cell lymphoma. Hematol J 2001; 2: 393–5
   PubMedGoogle Scholar
• Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports. Leuk Lymphoma 2002; 43: 133–7
   PubMed Web of Science ®Google Scholar
• Kyriakou C, Canals C, Goldstone A, Caballero D, Metzner B, Kobbe G, et al. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: Complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008; 26(2)218–24
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Conde E, Gutierrez A, Arranz R, Gandarillas M, Leon A, et al. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: The GELTAMO experience. Eur J Haematol 2007; 78(4)290–6
   PubMed Web of Science ®Google Scholar
• Schetelig J, Fetscher S, Reichle A, Berdel WE, Beguin Y, Brunet S, et al. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 2003; 88(11)1272–8
   PubMed Web of Science ®Google Scholar
• Gerlando Q, Barbera V, Ammatuna E, Franco V, Florena AM, Mariani G. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone. Haematologica 2000; 85: 880–1
   PubMed Web of Science ®Google Scholar
• Bourgeois E, Auxenfants E, Jouffrey C, Dubest C, Mahieu M, Rose C. Efficacy of fludarabine in the treatment of angioimmunoblastic lymphoma (AIL)]. Ann Med Interne (Paris) 2000; 151: 230–1
   PubMedGoogle Scholar
• Hast R, Jacobsson B, Petrescu A, Hjalmar V. Successful treatment with fludarabine in two cases of angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 1999; 34: 597–601
   PubMed Web of Science ®Google Scholar
• Pautier P, Devidas A, Delmer A, Dombret H, Sutton L, Zini JM, et al. Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 1999; 32((5–6))545–52
   PubMed Web of Science ®Google Scholar